Does TILDRAKIZUMAB Cause Psoriasis? 37 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Psoriasis have been filed in association with TILDRAKIZUMAB (ILUMYA). This represents 4.3% of all adverse event reports for TILDRAKIZUMAB.
37
Reports of Psoriasis with TILDRAKIZUMAB
4.3%
of all TILDRAKIZUMAB reports
3
Deaths
12
Hospitalizations
How Dangerous Is Psoriasis From TILDRAKIZUMAB?
Of the 37 reports, 3 (8.1%) resulted in death, 12 (32.4%) required hospitalization.
Is Psoriasis Listed in the Official Label?
Yes, Psoriasis is listed as a known adverse reaction in the official FDA drug label for TILDRAKIZUMAB.
What Other Side Effects Does TILDRAKIZUMAB Cause?
Product dose omission issue (53)
Death (50)
Drug ineffective (50)
Urinary tract infection (36)
Pneumonia (33)
Off label use (27)
Condition aggravated (25)
Covid-19 (25)
Inappropriate schedule of product administration (22)
Cerebrovascular accident (20)
What Other Drugs Cause Psoriasis?
SECUKINUMAB (21,976)
APREMILAST (19,255)
ADALIMUMAB (16,698)
ETANERCEPT (10,818)
RISANKIZUMAB-RZAA (6,896)
METHOTREXATE (6,283)
USTEKINUMAB (4,955)
INFLIXIMAB (3,524)
CERTOLIZUMAB PEGOL (3,428)
IXEKIZUMAB (2,818)
Which TILDRAKIZUMAB Alternatives Have Lower Psoriasis Risk?
TILDRAKIZUMAB vs TILDRAKIZUMAB-ASMN
TILDRAKIZUMAB vs TILIDINE
TILDRAKIZUMAB vs TIMOLOL
TILDRAKIZUMAB vs TIMOLOL\TRAVOPROST
TILDRAKIZUMAB vs TINIDAZOLE